PLoS ONE (Jan 2016)

Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration.

  • Maheswara R Duvvari,
  • Johannes P H van de Ven,
  • Maartje J Geerlings,
  • Nicole T M Saksens,
  • Bjorn Bakker,
  • Arjen Henkes,
  • Kornelia Neveling,
  • Marisol del Rosario,
  • Dineke Westra,
  • Lambertus P W J van den Heuvel,
  • Tina Schick,
  • Sascha Fauser,
  • Camiel J F Boon,
  • Carel B Hoyng,
  • Eiko K de Jong,
  • Anneke I den Hollander

DOI
https://doi.org/10.1371/journal.pone.0152047
Journal volume & issue
Vol. 11, no. 3
p. e0152047

Abstract

Read online

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly people worldwide. Cuticular drusen (CD) is a clinical subtype of AMD, which typically displays an earlier age at onset, and has a strong genetic component. Genetic studies support a role for rare sequence variants in CD susceptibility, and rare sequence variants in the CFH gene have been identified in 8.8% of CD cases. To further explore the role of rare variants in CD, we performed whole exome sequencing (WES) in 14 affected members of six families and 12 sporadic cases with CD. We detected rare sequence variants in CFH and FBLN5, which previously were shown to harbor rare variants in patients with CD. In addition, we detected heterozygous rare sequence variants in several genes encoding components of the extracellular matrix (ECM), including FBLN1, FBLN3/EFEMP1, FBLN5, FBLN6/HMCN1, FBN2, and COL15A1. Two rare pathogenic variants were identified in the COL15A1 gene: one in a sporadic case and another was found to segregate in a family with six affected individuals with CD. In addition, two rare pathogenic variants were identified in the FGL1 gene in three unrelated CD cases. These findings suggest that alterations in the ECM and in the coagulation pathway may play a role in the pathogenesis of CD. The identified candidate genes require further analyses in larger cohorts to confirm their role in the CD subtype of AMD. No evidence was found of rare sequence variants in a single gene that segregate with CD in the six families, suggesting that the disease is genetically heterogeneous.